Lymphatic malformation

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
mTOR inhibitor 1 substance
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Relay Therapeutics Inc. Commercial
    RLY-2608
    2024-518895-30-00 7 countries 2025 n=99
    Recruiting
  • Centre Hospitalier Regional Universitaire De Tours Academic
    SIROLIMUS
    2024-515955-39-01 1 country 2020 n=12
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Relay Therapeutics Inc. Commercial 1 Phase II 1
Centre Hospitalier Regional Universitaire De Tours Academic 1 Phase II 0
New trials by year
2020
1
2025
1
← All indication landscapes